Vincamine

Vincamine

SCHEMBL6631357

C=C.CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.96
KCNH2 Q12809 3/20 0.96
CYP2D6 P10635 3/20 0.96
HIF1A Q16665 3/20 0.96
MEN1 O00255 3/20 0.96
KMT2A Q03164 3/20 0.96
KDM4E B2RXH2 2/20 0.96
MAPT P10636 2/20 0.96
GAA P10253 1/20 0.96
CASP6 P55212 1/20 0.96
L3MBTL1 Q9Y468 1/20 0.96
NR1I2 O75469 3/20 0.76
PDE4D Q08499 2/20 0.76
HRH3 Q9Y5N1 2/20 0.76
OPRK1 P41145 1/20 0.76
LMNA P02545 3/20 0.55
CYP1A2 P05177 2/20 0.55
TSHR P16473 2/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Vincamine SCHEMBL30892136 0.98 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL8970683 0.98 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL3767 0.98 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL29710919 0.98 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL14095103 0.98 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL147179 0.98 CYP3A4 (1.00) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL6675845 0.97 CYP3A4 (0.92) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL8134417 0.97 CYP3A4 (0.98) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL5712113 0.96 CYP3A4 (0.96) CYP3A4KCNH2CYP2D6HIF1AMEN1
Vincamine SCHEMBL7462345 0.96 CYP3A4 (0.89) CYP3A4KCNH2CYP2D6HIF1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574317-B1 A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor ROUSSEL UCLAF (FR) 1996-10-09 EP claimed
EP-0488383-B1 2-beta,19-ethylene bridged steroids as aromatase inhibitors MERRELL PHARMA INC (US) 1996-09-11 EP claimed
EP-0574317-A1 A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor ROUSSEL UCLAF (FR) 1993-12-15 EP claimed
EP-1309594-B1 BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2004-12-15 EP disclosed
EP-1309594-A1 BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF Sanofi-Aventis (FR) 2003-05-14 EP disclosed
WO-2002012239-A1 BENZIMIDAZOLE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-SYNTHELABO (FR) 2002-02-14 WO disclosed
EP-0574317-B1 A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor ROUSSEL UCLAF (FR) 1996-10-09 EP disclosed
EP-0574317-A1 A new process for the preparation of 20-keto, 21-alpha-hydroxy steroids and intermediates therefor ROUSSEL UCLAF (FR) 1993-12-15 EP disclosed
EP-0059146-B1 MEDICAMENTS DERIVED FROM 3-HYDROXY DODECAHYDRO BENZ(E) INDEN-7-ON, PRODUCTS DERIVED FROM 3-HYDROXY DODECAHYDRO BENZ(E) INDEN-7-ON AND PROCESS FOR THEIR PREPARATION ROUSSEL-UCLAF (FR) 1985-09-25 EP disclosed
EP-0059146-A1 Medicaments derived from 3-hydroxy dodecahydro benz(e) inden-7-on, products derived from 3-hydroxy dodecahydro benz(e) inden-7-on and process for their preparation ROUSSEL-UCLAF (FR) 1982-09-01 EP disclosed